• Trial Talks Podcast
  • COVID-19
  • Blog
  • Client Login

Cancer Insight

Meet Our Partner

Cancer Insight

Cancer Insight

Cancer Insight is a full-service, mid-size CRO that specializes in designing and executing Phase I-IIb immuno-oncology (IO) trials.  Cancer Insight is hyper-focused on commercializing novel IO therapies.  Our mission is to help sponsors bring new IO therapies to the market for the benefit of cancer patients. Cancer Insight designs IO trials from a clinician’s perspective with a patient-centered focus.

Cancer Insight provides these services to sponsors: clinical trial design; IND creation and submission to the FDA; data management; trial master file creation and maintenance; biostatistics; clinical trial operations; regulatory affairs; business operations; management of clinical trial supplies; management of investigational products, clinical trial supplies, and specimens; QA/QC; and medical writing.  Cancer Insight team has completed over 35 IO studies (12 in progress), developed and submitted 21 IND Applications, and assisted with the creation of over 100 patents.  Cancer Insight has strong relationships with over 70 high-performing academic hospitals and cancer centers throughout the United States and collaborations with many of the subject matter experts in the IO field. For more information, please visit http://www.cancerinsight.com